(Konstantinopoulos et al., 2020) Given CCNE1 amplification and BRCA1/2 mutations are mutually exclusive, there is thought that CCNE1 amplified cancers are reliant on a proficient homologous recombination pathway. The gene discussed is CCNE1; the disease is cancer.